These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7891280)

  • 1. Structural studies of commercial fat emulsions used in parenteral nutrition.
    Li J; Caldwell KD
    J Pharm Sci; 1994 Nov; 83(11):1586-92. PubMed ID: 7891280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for the early evaluation of the effects of storage and additives on the stability of parenteral fat emulsions.
    Li J; Caldwell KD; Anderson BD
    Pharm Res; 1993 Apr; 10(4):535-41. PubMed ID: 8483835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical stability assessments of lipid emulsions of varying oil composition.
    Driscoll DF; Giampietro K; Wichelhaus DP; Peterss H; Nehne J; Niemann W; Bistrian BR
    Clin Nutr; 2001 Apr; 20(2):151-7. PubMed ID: 11327743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of fluorocarbon-in-water emulsions with added triglyceride.
    Weers JG; Arlauskas RA; Tarara TE; Pelura TJ
    Langmuir; 2004 Aug; 20(18):7430-5. PubMed ID: 15323486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compositional heterogeneity in parenteral lipid emulsions after sedimentation field flow fractionation.
    Venkatesh S; Li J; Caldwell KD; Anderson BD
    J Pharm Sci; 1998 Jul; 87(7):859-66. PubMed ID: 9649355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of commercial parenteral lipid emulsions repacking to polypropylene syringes.
    Watrobska-Swietlikowska D
    PLoS One; 2019; 14(4):e0214451. PubMed ID: 30970011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of size distribution and density of a pharmaceutical fat emulsion, using field-programmed sedimentation field-flow fractionation (SdFFF).
    Levin S; Klausner E
    Pharm Res; 1995 Aug; 12(8):1218-24. PubMed ID: 7494837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Providing a Combination Lipid Emulsion Compared With a Standard Soybean Oil Lipid Emulsion in Children Receiving Parenteral Nutrition: A Systematic Review and Meta-Analysis.
    Finn KL; Chung M; Rothpletz-Puglia P; Byham-Gray L
    JPEN J Parenter Enteral Nutr; 2015 Aug; 39(6):656-67. PubMed ID: 25057053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dispersed droplets as active fillers in fat-crystal network-stabilized water-in-oil emulsions.
    Rafanan R; Rousseau D
    Food Res Int; 2017 Sep; 99(Pt 1):355-362. PubMed ID: 28784493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particle size reduction of emulsions by formulation design. I: Effect of polyhydroxy alcohols.
    Chanana GD; Sheth BB
    J Parenter Sci Technol; 1993; 47(3):130-4. PubMed ID: 8360805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic study of aggregation of milk protein and/or surfactant-stabilized oil-in-water emulsions by sedimentation field-flow fractionation.
    Kenta S; Raikos V; Vagena A; Sevastos D; Kapolos J; Koliadima A; Karaiskakis G
    J Chromatogr A; 2013 Aug; 1305():221-9. PubMed ID: 23899382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature.
    Kadam AN; Najlah M; Wan KW; Ahmed W; Crean SJ; Phoenix DA; Taylor KM; Elhissi AM
    Pharm Dev Technol; 2014 Dec; 19(8):999-1004. PubMed ID: 24093888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose Ca2+ additive under clinical application circumstances.
    Télessy IG; Balogh J; Szabó B; Csempesz F; Zelkó R
    Nutr J; 2012 May; 11():32. PubMed ID: 22591808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agglutination of intravenously administered phosphatidylcholine-containing lipid emulsions with serum C-reactive protein.
    Tugirimana P; Speeckaert MM; Fiers T; De Buyzere ML; Kint J; Benoit D; Delanghe JR
    Nutr Clin Pract; 2013 Apr; 28(2):253-9. PubMed ID: 23454723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of techniques for evaluating the physical stability of parenteral emulsions.
    Zhang X; Kirsch LE
    PDA J Pharm Sci Technol; 2003; 57(4):300-15. PubMed ID: 14558703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between erythrocytes and free phospholipids as an emulsifying agent in fat emulsions or drug carrier emulsions for intravenous injections.
    Ishii F; Nagasaka Y
    Colloids Surf B Biointerfaces; 2004 Aug; 37(1-2):43-7. PubMed ID: 15450307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual asymmetric centrifugation as an alternative preparation method for parenteral fat emulsions in preformulation development.
    Tenambergen F; Maruiama CH; Mäder K
    Int J Pharm; 2013 Apr; 447(1-2):31-7. PubMed ID: 23454573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical properties of emulsion-based hydroxypropyl methylcellulose films: effect of their microstructure.
    Zúñiga RN; Skurtys O; Osorio F; Aguilera JM; Pedreschi F
    Carbohydr Polym; 2012 Oct; 90(2):1147-58. PubMed ID: 22840052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phospholipid emulsifiers on physicochemical properties of intravenous fat emulsions and/or drug carrier emulsions.
    Ishii F; Sasaki I; Ogata H
    J Pharm Pharmacol; 1990 Jul; 42(7):513-5. PubMed ID: 1980297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral nutrition admixtures for pediatric patients compounded with highly refined fish oil-based emulsion: assessment of physicochemical stability.
    Forchielli ML; Bonoli A; Preite I; Stancari A; Maselli S; Guarguaglini AM; Mignini I; Masi M; Puggioli C; Bersani G
    Clin Nutr; 2014 Dec; 33(6):1127-31. PubMed ID: 24411491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.